Upload Image (Max 20MB per Image)
Novartis has won FDA approval for Afinitor (everolimus) tablets for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer (advanced HR+ breast cancer) in combination with exemestane after ...
Tags: FDA approval, breast cancer, Afinitor tablets